ISO Group Logo
Defense and Aerospace
Supply Chain Partner
A Dynatech International Company


NSN 6505-01-360-5739, 6505013605739
PANCRELIPASE DELEAYED-RELEASE CAPSULES,USP

Federal Supply Classification
FSC 6505 - Drugs and Biologicals
National Item Identification Number
NIIN 013605739
Codification Country
United States
Item Name Code
INC 66747
Criticality
(X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code
(P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.
Availability: Request Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know
  CALL ABOUT NSN 6505-01-360-5739
Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

  REQUEST QUOTE for 6505-01-360-5739


Have a list that needs to be quoted? Upload it here.

DLMS® Summary

National Stock Number 6505-01-360-5739

National Stock Number (NSN) 6505-01-360-5739, or NIIN 013605739, (pancrelipase deleayed-release capsules,usp) was assigned June 28, 1992 in the Federal Logistics Information System (FLIS). NIIN 013605739 was cancelled on January 2, 2015, with a cancelled status of "Item is Cancelled WITHOUT Replacement." There is no known replacement specified for this stock number. This NSN does not replace any other NSNs.

There are 6 manufacturer part numbers associated with this NSN. One of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 3 suppliers. Today, 2 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 2 suppliers are deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years.

Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 01, 2020, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 66747. []. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505013605739 does not contain precious metals.

This information was last updated on .


Technical Characteristics

CAPSULE CONTENT FORM
(CQLS) ANY ACCEPTABLE
PART NAME ASSIGNED BY CONTROLLING AGENCY
(CXCY) PANCRELIPASE DELAYED-RELEASE CAPSULES 100S BT
SPECIAL FEATURES
(FEAT) CONTAINS 20,000 USP UNITS LIPASE ACTIVE INGREDIENT,65,000 USP UNITS AMYLASE ACTIVE INGREDIENT AND 65,0000 USP UNITS PROTEASE ACTIVE INGREDIENT; ENTERIC COATED
PRIMARY CONTAINER TYPE
(CQCT) BOTTLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY
(CYLZ) 100.000
CAPSULE TYPE
(AKJC) ANY ACCEPTABLE

Manufacturer Part Numbers


Related Inventory



 
Top